62
Participants
Start Date
June 27, 2023
Primary Completion Date
November 30, 2027
Study Completion Date
December 31, 2027
Psilocybin
Participants will receive two doses of psilocybin (10mg, 25mg).
Cognitive behavioral therapy
Twelve total sessions of therapy, including manualized cognitive behavioral therapy for major depressive disorder, including psychoeducation about depression, cognitive skills, and behavioral skills as well as preparation for psilocybin.
Minimal therapeutic support
Six total therapy sessions. Preparation for psilocybin in the first three sessions plus supportive, nondirective psychotherapy in the final three sessions.
RECRUITING
UCLA Semel Institute, Los Angeles
National Center for Complementary and Integrative Health (NCCIH)
NIH
University of California, Los Angeles
OTHER